相关实验视频

Updated: Jul 9, 2026

Localized RNAi and Ectopic Gene Expression in the Medicinal Leech

Localized RNAi and Ectopic Gene Expression in the Medicinal Leech

Published on: April 17, 2008

在四种药用水物种中比较研究取的三酶抑制基因

Mingkang Xiao¹, Fang Zhao¹, Tianyu Ye¹

¹Key Laboratory of Jiangxi Province for Biological Invasion and Biosecurity, School of Life Sciences, Jinggangshan University, Ji'an 343009, China.

|September 27, 2025

概括

药用吸血虫产生抗血栓蛋白质,但它们的多样性尚不清楚. 这项研究发现,Hirudinaria manillensis具有最强的抗凝活性和保存的基因,使其成为治疗开发的理想选择.

科学领域:

生物化学生物化学
基因组学就是基因组学.
药理学药理学是指药理学的学科.

背景情况:

吸血虫是具有药用价值的类动物,产生抗血栓蛋白质.
了解这些生物活性成分的物种间变异至关重要.

研究的目的:

为了分析四种水物种中水衍生型酸酶抑制剂 (LDTI) 基因的多样性和功能活性.
根据LDTI特征,确定治疗开发的最佳吸血虫物种.

主要方法:

下一代测序来分析LDTI基因.
皮奇亚牧羊人的真核表达系统用于蛋白质生产.
在使用色素基质的体外抗凝剂测定.

主要成果:

在非血吸血的血 (Whitmania pigra,Whitmania laevis) 与血吸血物种 (Hirudinaria manillensis,Hirudo nipponia) 相比,观察到较高的LDTI基因遗传变异.
在H. manillensis中进行净化选择 (ω = 0.47);在其他人中进行中性或弱正选择 (ω ≥ 1).
在血吸血者吸血者中显著更高的LDTI表达,在H. manillensis (2942.07 ± 1593.12 TPM) 中达到峰值.
所有物种都表现出抗凝活动;H. manillensis表现出最强大的抑制作用.

结论:

所有四种研究的水物种都具有抗血栓潜力.
Hirudinaria manillensis是治疗开发的最佳候选者,原因是保存的LDTI序列,高表达率和强大的抗凝活性.

关键词:

它具有抗凝固活性的抗凝固活性.抗血栓基因是一种抗血栓基因.单核细胞表达的表达方式遗传变异是一种遗传变异.药用吸血虫是一种药用吸血虫.

更多相关视频

Intracellular Recording, Sensory Field Mapping, and Culturing Identified Neurons in the Leech, Hirudo medicinalis

Intracellular Recording, Sensory Field Mapping, and Culturing Identified Neurons in the Leech, Hirudo medicinalis

Published on: November 4, 2013

Isolation of Viable Multicellular Glands from Tissue of the Carnivorous Plant, Nepenthes

Isolation of Viable Multicellular Glands from Tissue of the Carnivorous Plant, Nepenthes

Published on: December 22, 2013

相关概念视频

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...